BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9244387)

  • 1. Disulfide structure of the heparin binding domain in vascular endothelial growth factor: characterization of posttranslational modifications in VEGF.
    Keck RG; Berleau L; Harris R; Keyt BA
    Arch Biochem Biophys; 1997 Aug; 344(1):103-13. PubMed ID: 9244387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a soluble form of human CD4. Peptide analyses confirm the expected amino acid sequence, identify glycosylation sites and demonstrate the presence of three disulfide bonds.
    Harris RJ; Chamow SM; Gregory TJ; Spellman MW
    Eur J Biochem; 1990 Mar; 188(2):291-300. PubMed ID: 2318210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disulfide bonds in native and recombinant fish growth hormones.
    Vestling M; Murphy C; Fenselau C; Chen TT
    Mol Mar Biol Biotechnol; 1991 Sep; 1(1):73-7. PubMed ID: 1845473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Closely related glycosylation patterns of recombinant human IL-2 expressed in a CHO cell line and natural IL-2.
    Vita N; Magazin M; Marchese E; Lupker J; Ferrara P
    Lymphokine Res; 1990; 9(1):67-79. PubMed ID: 2109157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring protein cleavage and concurrent disulfide bond assignment using thermospray LC/MS.
    Stachowiak K; Otlewski J; Polanowski A; Dyckes DF
    Pept Res; 1990; 3(3):148-54. PubMed ID: 2134058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disulfide bridges in tomato pectinesterase: variations from pectinesterases of other species; conservation of possible active site segments.
    Markovic O; Jörnvall H
    Protein Sci; 1992 Oct; 1(10):1288-92. PubMed ID: 1303747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and NH2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor.
    Senger DR; Connolly DT; Van de Water L; Feder J; Dvorak HF
    Cancer Res; 1990 Mar; 50(6):1774-8. PubMed ID: 2155059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-translational processing of membrane-associated recombinant human stem cell factor expressed in Chinese hamster ovary cells.
    Lu HS; Clogston CL; Wypych J; Parker VP; Lee TD; Swiderek K; Baltera RF; Patel AC; Chang DC; Brankow DW
    Arch Biochem Biophys; 1992 Oct; 298(1):150-8. PubMed ID: 1381905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of the glycosylation patterns, disulfide linkages, and protein heterogeneities of baculovirus-expressed mouse interleukin-3 by mass spectrometry.
    Knepper TP; Arbogast B; Schreurs J; Deinzer ML
    Biochemistry; 1992 Nov; 31(46):11651-9. PubMed ID: 1445902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-translational modifications of recombinant human tissue factor.
    Paborsky LR; Harris RJ
    Thromb Res; 1990 Dec; 60(5):367-76. PubMed ID: 2084958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of bovine heparin-binding neurotrophic factor (HBNF): assignment of disulfide bonds.
    Fabri L; Nice EC; Ward LD; Maruta H; Burgess AW; Simpson RJ
    Biochem Int; 1992 Oct; 28(1):1-9. PubMed ID: 1445382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human recombinant CuZn-superoxide dismutase. Amino acid sequence and location of the disulfide bond.
    Peretz M; Werber MU; Burstein Y
    Int J Pept Protein Res; 1991 Feb; 37(2):122-7. PubMed ID: 2019474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyper-heterogeneity of the N-terminus of recombinant BSF-2/IL-6 produced in CHO and NIH3T3 cells.
    Tonouchi N; Miyasaka Y; Matsui H; Miwa K
    Agric Biol Chem; 1990 Oct; 54(10):2685-8. PubMed ID: 1368601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass spectrometric characterization of recombinant human interleukins 1 beta.
    Pucci P; Siciliano R; Ferranti P; Malorni A; Marino G
    Biotechnol Appl Biochem; 1990 Aug; 12(4):357-63. PubMed ID: 2205245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms.
    Houck KA; Leung DW; Rowland AM; Winer J; Ferrara N
    J Biol Chem; 1992 Dec; 267(36):26031-7. PubMed ID: 1464614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Confirming the primary structures of insulin-like growth factors 1 and 2 isolated from porcine plasma using mass analysis.
    Bayne SJ; Thomsen J; Skriver L; van den Brande JL; Hoogerbrugge CM; van Buul-Offers SC
    Pept Res; 1990; 3(6):271-3. PubMed ID: 2134070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and characterization of soluble forms of human and rat stem cell factor recombinantly expressed by Escherichia coli and by Chinese hamster ovary cells.
    Langley KE; Wypych J; Mendiaz EA; Clogston CL; Parker VP; Farrar DH; Brothers MO; Satygal VN; Leslie I; Birkett NC
    Arch Biochem Biophys; 1992 May; 295(1):21-8. PubMed ID: 1374224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carboxyl-terminal structure of basic fibroblast growth factor significantly contributes to its affinity for heparin.
    Seno M; Sasada R; Kurokawa T; Igarashi K
    Eur J Biochem; 1990 Mar; 188(2):239-45. PubMed ID: 2180699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the structure of platelet-derived growth factor AA: C-terminal processing, epitopes, and characterization of cysteine residues.
    Jaumann M; Hoppe V; Tatje D; Eichner W; Hoppe J
    Biochemistry; 1991 Apr; 30(13):3303-9. PubMed ID: 1706938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of recombinant human interleukin 5 produced by Chinese hamster ovary cells.
    Minamitake Y; Kodama S; Katayama T; Adachi H; Tanaka S; Tsujimoto M
    J Biochem; 1990 Feb; 107(2):292-7. PubMed ID: 2361960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.